Irritable Bowel Syndrome News

UroToday.com - Unexplained clinical conditions have been referred to by many names including functional somatic syndromes.

This report provides insight into the pipeline status of irritable bowel syndrome drugs by company and by stage as well as a summary of the latest news and developments in this area.

November 24, 2009 - Comments LXRX A A A A A A With many key trial results being announced over the next 12 months,this biotech seems like a logical addition to anyones portfolio,with a fairly low degree of risk at this currently depressed stock priceA of $1.63A A A A A A A A Key DevelopmentsA A Lexicon completed patient enrollment ahead of schedule ...

Nov 25, 2009 - Sucampo Pharma Europe, Ltd., and Sucampo Pharma Americas, Inc., subsidiaries of Sucampo Pharmaceuticals, Inc.

Find out what a sputtering economy and an increasingly difficult to crack job market means to you.

ALISO VIEJO,A Calif. A division of Valeant Pharmaceuticals has launched an authorized generic of an irritable bowel syndrome treatment.

Valeant Pharmaceuticals said Monday it began selling a generic version of Librax, a treatment for irritable bowel syndrome drug.

Two more privately-held companies are looking to enter the market, Ironwood Pharmaceuticals and Fabrinet .

PPD, Inc. today announced it has entered an agreement with Janssen Pharmaceutica N.V. to develop and commercialize two Phase II-ready therapeutic compounds, one to treat diarrhea-predominant irritable bowel syndrome and the other to treat complicated skin and skin structure and respiratory infections.

Eating disorder patients display a high prevalence of gastrointestinal symptoms and functional gastrointestinal disorders such as irritable bowel syndrome.

Ironwood did not specify in yesterday's filing how much it plans to raise by selling stock.

Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc. , today announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza 24 microgram gel capsules for the long-term treatment of patients with chronic idiopathic constipation .

Many of us don't really know the differences between the symptoms of the common cold and the flu.

PPD, Inc. has entered an agreement with Janssen Pharmaceutica to develop and commercialize two Phase II therapeutic compounds, one for diarrhea-predominant irritable bowel syndrome and one for complicated skin and skin structure and respiratory infections.

Clinical research organization PPD on Tuesday announced it has reached an agreement with Belgian drug company Janssen Pharmaceutica N.V. to develop two compounds in a deal that could be worth hundreds of millions of dollars for both companies if the products reach the market.

Hypnosis has a "very real" effect that can be picked up on brain scans, say Hull University researchers.

Lexicon Pharmaceuticals Inc. said Friday an irritable bowel syndrome drug candidate met its goals in a mid-stage clinical trial.

IBS is more common in women. Fotalia Irritable bowel syndrome, or IBS, is a very common disorder of the digestive tract.

Wall Street News Alert is issuing its "Daily Market Movers Report" for Friday morning.

GastroIntestinal / Gastroenterology Lexicon Pharmaceuticals, Inc. announced that the company's investigational new drug, LX1031, a tryptophan hydroxylase inhibitor, demonstrated positive results in clinically important parameters for the treatment of non-constipating irritable bowel syndrome .